[{"address1": "240 East Grand Avenue", "address2": "2nd Floor", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "650 388 5600", "website": "https://www.oricpharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies to counter the resistance mechanisms cancers in the United States. Its clinical stage product candidates include ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor, currently under Phase 1b study, that selectively target epidermal growth factor receptor (EGFR) exon 20 and human epidermal growth factor receptor 2 exon 20 with high potency towards exon 20 insertion mutations; and ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 for prostate cancer, currently under Phase 1b study. The company develops ORIC-533, an orally bioavailable small molecule inhibitor of CD73; and ORIC-613, a small molecule therapeutic intended to address a mechanism of innate resistance found in a subset of breast cancers. It has clinical development collaboration agreement for a potential Phase 2 study of ORIC-533 in multiple myeloma with Pfizer Inc.; a clinical trial collaboration and supply agreement with Bayer to evaluate ORIC-944 in combination with Nubeqa AR inhibitor; and a clinical trial collaboration and supply agreement with Johnson & Johnson to evaluate ORIC 944 in combination with Erleada AR inhibitor. The company was incorporated in 2014 and is headquartered in South San Francisco, California.", "fullTimeEmployees": 128, "companyOfficers": [{"maxAge": 1, "name": "Dr. Richard A. Heyman Ph.D.", "age": 67, "title": "Founder, Independent Chairman & Member of Scientific Advisory Board", "yearBorn": 1957, "fiscalYear": 2024, "totalPay": 100000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jacob M. Chacko M.B.A., M.D.", "age": 45, "title": "President, CEO & Director", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 1039037, "exercisedValue": 0, "unexercisedValue": 8489789}, {"maxAge": 1, "name": "Mr. Dominic G. Piscitelli CPA, M.B.A.", "age": 49, "title": "Chief Financial Officer", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 684155, "exercisedValue": 0, "unexercisedValue": 1460951}, {"maxAge": 1, "name": "Dr. Pratik S. Multani M.D., M.S.", "age": 57, "title": "Chief Medical Officer", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 735587, "exercisedValue": 0, "unexercisedValue": 2520060}, {"maxAge": 1, "name": "Dr. Charles L. Sawyers B.A., M.D., Ph.D.", "age": 65, "title": "Founder & Member of Scientific Advisory Board", "yearBorn": 1959, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Scott W. Lowe Ph.D.", "title": "Founder & Member of Scientific Advisory Board", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Kevin  Brodbeck Ph.D.", "title": "Chief Technical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lori Sickels Friedman Ph.D.", "age": 59, "title": "Chief Scientific Officer", "yearBorn": 1965, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Christian V. Kuhlen Esq., J.D., M.D.", "age": 51, "title": "General Counsel", "yearBorn": 1973, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel  Iazzetti", "title": "VP & Head of People", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 10, "boardRisk": 6, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1759276800, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 13.34, "open": 13.24, "dayLow": 13.03, "dayHigh": 13.57, "regularMarketPreviousClose": 13.34, "regularMarketOpen": 13.24, "regularMarketDayLow": 13.03, "regularMarketDayHigh": 13.57, "payoutRatio": 0.0, "beta": 1.676, "forwardPE": -6.4827585, "volume": 1169767, "regularMarketVolume": 1169767, "averageVolume": 1213235, "averageVolume10days": 1170070, "averageDailyVolume10Day": 1170070, "bid": 13.12, "ask": 13.26, "bidSize": 5, "askSize": 2, "marketCap": 1278138496, "fiftyTwoWeekLow": 3.895, "fiftyTwoWeekHigh": 14.93, "allTimeHigh": 40.81, "allTimeLow": 2.36, "fiftyDayAverage": 11.7517, "twoHundredDayAverage": 9.175225, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1003710528, "profitMargins": 0.0, "floatShares": 63511635, "sharesOutstanding": 97122987, "sharesShort": 13020257, "sharesShortPriorMonth": 9528668, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.1341, "heldPercentInsiders": 0.06712, "heldPercentInstitutions": 0.99273, "shortRatio": 7.74, "shortPercentOfFloat": 0.1358, "impliedSharesOutstanding": 97122987, "bookValue": 3.759, "priceToBook": 3.500931, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -137248992, "trailingEps": -1.89, "forwardEps": -2.03, "enterpriseToEbitda": -6.76, "52WeekChange": 0.38818562, "SandP52WeekChange": 0.19736934, "quoteType": "EQUITY", "currentPrice": 13.16, "targetHighPrice": 25.0, "targetLowPrice": 12.0, "targetMeanPrice": 18.27273, "targetMedianPrice": 19.0, "recommendationMean": 1.16667, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 11, "totalCash": 282512992, "totalCashPerShare": 2.909, "ebitda": -148484000, "totalDebt": 8085000, "quickRatio": 15.652, "currentRatio": 16.129, "debtToEquity": 2.495, "returnOnAssets": -0.27685, "returnOnEquity": -0.43822, "freeCashflow": -72467752, "operatingCashflow": -120226000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ORIC", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "fiftyDayAverageChange": 1.4082994, "fiftyDayAverageChangePercent": 0.11983793, "twoHundredDayAverageChange": 3.9847746, "twoHundredDayAverageChangePercent": 0.4342972, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.2 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1587735000000, "postMarketChangePercent": -0.83510274, "postMarketPrice": 13.0501, "postMarketChange": -0.10989952, "regularMarketChange": -0.18, "regularMarketDayRange": "13.03 - 13.57", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1213235, "fiftyTwoWeekLowChange": 9.264999, "fiftyTwoWeekLowChangePercent": 2.3786905, "fiftyTwoWeekRange": "3.895 - 14.93", "fiftyTwoWeekHighChange": -1.7700005, "fiftyTwoWeekHighChangePercent": -0.11855327, "fiftyTwoWeekChangePercent": 38.81856, "earningsTimestampStart": 1762891200, "earningsTimestampEnd": 1762891200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.89, "epsForward": -2.03, "epsCurrentYear": -1.70621, "priceEpsCurrentYear": -7.7130013, "regularMarketChangePercent": -1.34933, "regularMarketPrice": 13.16, "marketState": "CLOSED", "shortName": "Oric Pharmaceuticals, Inc.", "longName": "ORIC Pharmaceuticals, Inc.", "corporateActions": [], "postMarketTime": 1761954626, "regularMarketTime": 1761940800, "exchange": "NMS", "messageBoardId": "finmb_303713108", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "ORIC Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-11-01"}]